INDIANAPOLIS, Indiana – Franciscan Health Indianapolis is one of the first few hospitals in Indiana to offer a novel treatment for emphysema, a severe form of chronic obstructive pulmonary disease (COPD).
The treatment uses the Zephyr® Valve system, an FDA-approved minimally invasive procedure requiring no incisions or cutting. The technology vastly improves patients' overall quality of life,
"We are proud to offer this new treatment because our severe COPD and emphysema patients struggle with each breath," said Faisal Khan, MD, an independent interventional pulmonologist who chooses to practive at Franciscan Health. "Until now, the only other options for these patients were highly invasive procedures such as lung transplants. Zephyr® has the potential to be a life-changer for many patients."
The one-time procedure is done during a simple 30-to-60 minute bronchoscopy that requires no incision. It places an average of four tiny Zephyr® valves that are placed in the airways to block diseased parts of the lungs. This reduces hyperinflation of the damaged areas and allows healthier lung tissue to expand and ease pressure off the diaphragm.
"This results in being less short of breath and have an easier time breathing," said Dr. Khan. "Clinical studies show that patients treated with Zephyr® valves enjoy a significantly improved quality of life compared to untreated patients."
To learn more or to see if patients qualify for Zephyr®, call (317) 528-PULM (7856).
By Joe Stuteville
Media Relations Manager